Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Growth Outlook Through 2024-2033

Overview and Scope
Messenger ribonucleic acid (mRNA) synthesis raw materials are ribonuclear materials that ensure the precise and efficient synthesis of mRNA molecules in in-vitro transcription processes to produce physiologically functioning synthetic RNAs. It is used to produce mRNA vaccines that induce the body to produce an immune response against the antigen, thereby expanding the body’s immune capacity.

Sizing and Forecast
The mrna synthesis raw materials market size has grown steadily in recent years. It will grow from $2.94 billion in 2023 to $3.02 billion in 2024 at a compound annual growth rate (CAGR) of 2.8%. The growth in the historic period can be attributed to biomedical research advancements, rising interest in vaccines and therapeutics, demand for personalized medicine, outbreak preparedness and response, biotech industry growth.

The mrna synthesis raw materials market size is expected to see steady growth in the next few years. It will grow to $3.39 billion in 2028 at a compound annual growth rate (CAGR) of 2.9%. The growth in the forecast period can be attributed to supply chain optimization, commercialization and market expansion, investments in biotech and pharma, regulatory support and approvals, therapeutic expansion. Major trends in the forecast period include emergence of new entrants, quality control and standardization, intellectual property and licensing, global access and equity, shift towards sustainable and scalable manufacturing.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/messenger-ribonucleic-acid-mrna-synthesis-raw-materials-global-market-report

Segmentation & Regional Insights
The messenger ribonucleic acid (mrna) synthesis raw materials market covered in this report is segmented –

1) By Type: Capping Agents, Nucleotides, Plasmid DNA, Other Types
2) By Applications: Therapeutics Production, Vaccine Production, Other Applications
3) By End-Users: Biotechnology Companies, Pharmaceutical Companies, Research And Academic Institutions, Other End-Users

North America was the largest region in the mRNA synthesis raw materials market in 2023. The regions covered in the messenger ribonucleic acid (mrna) synthesis raw materials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=12336&type=smp

Major Driver Impacting Market Growth
The growing incidence of cancer and chronic disorders is expected to propel the growth of the mRNA synthesis raw materials market going forward. Cancer is a disorder in which aberrant cells develop uncontrollably and can infiltrate neighbouring tissues and potentially move to other regions of the body via the blood and lymph systems. Chronic illnesses are described generically as problems that persist for a year or longer, need continuing medical treatment, impede everyday activities, or both. mRNA synthesis raw materials are used in drug discovery, vaccine development, and the manufacturing of therapeutics that are RNA-based to offer better immunogenicity, higher efficiency, and a short production time that can be used to treat cancer and chronic disorders. For instance, in 2020, according to Globocan, a Switzerland-based provider of a worldwide database of cancer incidence and mortality rates, there were around 19.29 million new cancer cases in 2020, and the number of cancer cases in the next five years is estimated to be 50.55 million. Furthermore, in April 2022, according to statistics published in the National Council on Aging’s report, a US-based charitable organization for older Americans with service providers and policymakers, approximately 80% of persons aged 65 and older will have at least one chronic ailment, with 68% having two or more in the United States. Therefore, the growing incidence of cancer and chronic disorders drives the mRNA synthesis of raw materials.

Key Industry Players

Major companies operating in the messenger ribonucleic acid (mRNA) synthesis raw materials market report are Pfizer Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Moderna Inc., Agilent Technologies Inc., Lonza Group Ltd., Eurofins Scientific, Bio-Rad Laboratories Inc., Qiagen N.V., Maravai LifeSciences, Takara Bio Inc., GenScript Biotech Corporation, Promega Corporation, Abcam PLC, BioLegend Inc., Integrated DNA Technologies Inc., Sino Biological Inc., CureVac N.V., LGC Biosearch Technologies, Enzo Biochem Inc., Merck KGaA, GeneCopoeia Inc., Bio-Synthesis Inc., BOC Sciences Inc., Bio Basic Inc., OriGene Technologies Inc., BioCat GmbH, Creative Biogene, Jena Bioscience GmbH, ATDBio Ltd.

The messenger ribonucleic acid (mrna) synthesis raw materials market report table of contents includes:

1. Executive Summary
2. mRNA Synthesis Raw Materials Market Characteristics
3. mRNA Synthesis Raw Materials Market Trends And Strategies
4. mRNA Synthesis Raw Materials Market – Macro Economic Scenario
5. Global mRNA Synthesis Raw Materials Market Size and Growth
.
.
.
31. mRNA Synthesis Raw Materials Market Other Major And Innovative Companies
32. Global mRNA Synthesis Raw Materials Market Competitive Benchmarking
33. Global mRNA Synthesis Raw Materials Market Competitive Dashboard
34. Key Mergers And Acquisitions In The mRNA Synthesis Raw Materials Market
35. mRNA Synthesis Raw Materials Market Future Outlook and Potential Analysis
36.Appendix

Explore the trending research reports from TBRC:

Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model